Common Cosmetics Direct Submission Errors to Avoid
A troubleshooting list of the frequent mistakes that cause rejected or inaccurate MoCRA product listings, and how to fix each one.
Cosmetics Direct is the FDA's portal for facility registration and product listing under MoCRA, and like most government portals, it's unforgiving about certain kinds of mistakes while being surprisingly lenient about others. Here's what actually trips people up, based on the patterns that keep showing up.
Registering the wrong entity as the facility
MoCRA requires facility registration for the place where a cosmetic is manufactured or processed, not the brand's headquarters if those are different addresses. Makers who contract with a co-packer sometimes register their own home office as the facility because that's where they run the business from, when the actual manufacturing facility, the co-packer's plant, is what needs to be registered. If you don't own the physical space where your product is made, check with your manufacturer about whether they've already registered that facility, since it may already be covered, and duplicate or incorrect registrations create confusion down the line.
Confusing facility registration with product listing
These are two separate steps in Cosmetics Direct, and people occasionally think completing one covers the other. Facility registration covers the physical location. Product listing covers each individual cosmetic product, its ingredients, and its listing details. You generally need both, and skipping product listing because you already did facility registration is a common gap.
Missing the responsible person designation
MoCRA requires a named responsible person, the entity responsible for ensuring safety substantiation and handling adverse event records. Submissions sometimes leave this vague or list a person who isn't actually positioned to handle that responsibility, like a contract packager who has no visibility into the brand's formulation choices. The responsible person should be whoever genuinely controls the product's safety substantiation, typically the brand owner.
Overlooking the small business exemption, in both directions
Some small businesses are exempt from registration and listing requirements under MoCRA. The errors here run in both directions: some eligible small makers submit anyway out of caution and end up with unnecessary registrations to maintain, while others assume they're exempt without actually checking whether their situation meets the exemption criteria, and skip a registration they needed. This exemption has specific conditions attached, and it's worth confirming your business genuinely qualifies rather than assuming based on size alone.
Listing ingredients under trade names instead of proper form
Trade names, the marketing names suppliers give their blends, never belong directly on a submission as if they were the ingredient itself. Every trade name needs to be mapped to what it actually contains before listing. This is the same principle that applies to Canadian filings: a supplier's "SilkGlow Complex" is a blend of several actual ingredients, and each one needs its own accounting, not a pass-through of the brand name.
Treating sunscreen as a cosmetic listing
This one causes real problems. Sunscreen is regulated as an OTC drug in the United States, not a cosmetic, so it doesn't belong in a cosmetic product listing at all. Makers who add "SPF 15" to a lip balm or moisturizer sometimes list the whole product as a cosmetic without recognizing that the SPF claim moved it into drug territory, which has an entirely different regulatory pathway with the FDA than cosmetic listing.
Letting the listing go stale after a formula change
A product listing reflects the formula at the time of filing. When you reformulate, swap a preservative, change a fragrance, adjust a concentration, the listing needs to be updated to match. Leaving an outdated listing on file after a real formula change is a common, quiet error that only surfaces if there's ever an adverse event investigation or an audit, at which point the listed formula doesn't match what's actually being sold.
Underestimating what safety substantiation means
MoCRA requires safety substantiation, and "I've been making this for years and nobody's complained" doesn't meet that bar on its own. Substantiation generally means documented evidence, safety data on ingredients, stability testing, or similar records that support the product being safe for its intended use. Submitting without having this backup documentation in place is a gap that doesn't show up in the portal itself but becomes a real problem if the FDA ever asks for it.
A quick self-check before you submit
Before finalizing a Cosmetics Direct submission, it's worth confirming: the facility address is the actual manufacturing location, the responsible person is genuinely accountable for safety substantiation, every trade-named ingredient has been resolved to its real components, nothing on the list is secretly a drug ingredient like an SPF actives package, and your listing reflects your current formula rather than an earlier version.
Getting the ingredient-mapping piece right across markets, resolving trade names, tracking supplier blend concentrations, is one of the more tedious parts of any cosmetic filing, whether it's a CNF in Canada or a listing in the US. Cosmetic Comply already handles that mapping for Canadian filings today, with the US listing workflow on the way, so the same ingredient data doesn't have to be rebuilt from scratch for each market.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Fragrance Allergen Labeling and the April 12 2026 List
What Canada's List 1 fragrance allergen disclosure means for your CNF and label starting April 12, 2026, and how to check your formula now.
How to List Multiple Products Under One Facility
A practical workflow for listing a growing catalog with the FDA under MoCRA without duplicating work or losing track of facility numbers.
Private Label Brands and Who Owns MoCRA Compliance
Working through a private label scenario to pin down who is legally the responsible person under MoCRA when reselling a stock formula.
Adverse Event Reporting and the 15 Business Day Rule
What counts as a serious adverse event under MoCRA, the reporting clock that starts ticking, and how submission through MedWatch works.